Respiratory inhaler devices market to hit $51.9b by 2034

Key drivers include developments in smart and sustainable designs.

The respiratory inhaler devices market is expected to reach $51.9b by 2034 at a compound annual growth rate (CAGR) of 4.8%, according to Allied Market Research.

The sector’s expansion is attributed to the increasing prevalence of chronic respiratory diseases, growing adoption of portable and home-based inhalation therapy, and developments in smart and sustainable inhaler designs.

“Moreover, the expansion of telemedicine, e-pharmacy distribution, and digital healthcare ecosystems has made inhalation therapy more accessible to patients worldwide,” the report said.

By product, the soft mist inhalers segment is expected to register the highest CAGR during the forecast period.